English
Specials
    Upgrade
    MoneycontrolBe a PRO
    Moneycontrol PRO
    you are here: HomeNewsBusinessMoneycontrol Research

    Atul Q1: Pharma and agrochem cushion the Covid impact

    Atul Industries is better positioned to deal with near-term hurdles with respect to operations, supply chain and working capital management

    Anubhav Sahu
    September 02, 2020 / 02:44 PM IST
    Atul Q1: Pharma and agrochem cushion the Covid impact

    PRO Only Highlights
    -      Quarterly performance largely backed by improved realisations
    -      Medium-term triggers China plus and protectionist measures for tyre industry
    -      Valuations not inexpensive; but improved medium-term outlook

    Highlights - Q1 performance hugely impacted for both Atul and Amal - Amal considering major capex; Atul executing ~Rs500 crore capex - China supply chain shift opportunity presents market share gains - Atul preferred play; accumulate on decline Shares of integrated chemicals manufacturer Atul Industries (CMP: Rs 5,944, Market Cap: Rs 17,633 crore) and its microcap subsidiary Amal Ltd (CMP: Rs 168, Market Cap: Rs 158 crore) have seen a decent rally after the equity market slump in March. Leading chemical entities with a stranglehold over a range...

    • PRO Panorama

      Moneycontrol Pro Panorama | Pharma companies to get inflation booster in FY24 

      Mar 28, 2023 / 02:26 PM IST

      In today’s edition of Moneycontrol Pro Panorama: India must build consensus on climate funding, fertiliser subsidy likely to dro...

      Read Now
    • PRO Weekender

      Moneycontrol Pro Weekender: Between the Fed and a hard place

      Mar 11, 2023 / 11:38 AM IST

      The Fed is caught between combating inflation and worries over a financial mishap

      Read Now

    To read the full story, Subscribe to Moneycontrol PRO

    Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

    View Plans

    Already a member? Sign in

    Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

    50% OFF

    What Do You Get

    • Ad free experience

      Experience a non-intrusive navigation and faster response in the ad free mode

    • Sharpest Opinions

      Access to 230+ exclusive stories per month from our editorial and Experts

    • +

      Have a Global edge with access to content from world renowned experts and journalist

    • Actionable Insights

      Access to 40+ weekly investment ideas including 4 daily technical calls

    • Virtual Events

      Exclusive access to live webinars from market experts on trading and investment strategies

    • Newsletters

      Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

    View Offers

    Get upto 50% discount on limited period offers